Sell 6/28/2024Downgrade
Treatment.com AI Inc. (TREIF) was downgraded to E+ from D- on 6/28/2024 due to a decline in the valuation index and volatility index.

Sell 6/14/2024Upgraded
Treatment.com AI Inc. (TREIF) was upgraded to D- from E+ on 6/14/2024 due to an increase in the volatility index.

Sell 5/24/2024Downgrade
Treatment.com AI Inc. (TREIF) was downgraded to E+ from D- on 5/24/2024 due to a decline in the volatility index.

Sell 5/9/2024Upgraded
Treatment.com AI Inc. (TREIF) was upgraded to D- from E+ on 5/9/2024 due to an increase in the total return index, volatility index and growth index.

Sell 4/19/2024Downgrade
Treatment.com AI Inc. (TREIF) was downgraded to E+ from D- on 4/19/2024 due to a decline in the volatility index.

Sell 4/4/2024Upgraded
Treatment.com AI Inc. (TREIF) was upgraded to D- from E+ on 4/4/2024 due to a large increase in the solvency index, total return index and volatility index. Debt to equity declined from -0.25 to -0.92.

Sell 3/14/2023Downgrade
Treatment.Com International Inc. (TREIF) was downgraded to E+ from D- on 3/14/2023 due to a decline in the total return index and valuation index.

Sell 1/27/2023Upgraded
Treatment.Com International Inc. (TREIF) was upgraded to D- from E+ on 1/27/2023 due to a substantial increase in the growth index, valuation index and volatility index. Operating cash flow increased 73.89% from -$299.9 to -$78.3, EBIT increased 42.86% from -$468.3 to -$267.6, and earnings per share increased from -$0.0072 to -$0.0043.

Sell 6/1/2022Upgraded
Treatment.Com International Inc. (TREIF) was upgraded to E+ from E on 6/1/2022 due to an increase in the volatility index.

Sell 3/2/2022Upgraded
Treatment.Com International Inc. (TREIF) was upgraded to E from E- on 3/2/2022 due to an increase in the valuation index.

Sell 11/24/2021None
Treatment.com AI Inc. (TREIF) was downgraded to E- from U on 11/24/2021.